Project Code: 10453854
Main Supervisor: Dr Kim Ward (kwar044)
Principal investigator: Dist Prof Jane Harding
Co supervisors: Ms Jen Rogers (jrog039), Dr Barry Milne (bmil080)
Application open date: 02 Sep 2019
Enrolment information: NZ Citizens, NZ Permanent Residents, International
Most new treatments of pregnant women and newborn babies are tested in clinical trials, which commonly focus on short term outcomes. However, treatments before and around the time of birth may have important effects on life-long health and development for both mother and baby. Evaluating these requires follow-up years after the initial trial, and is most useful if almost everyone participates.
Although thousands of women and babies may be involved in follow-up studies, there is almost no information about what families consider the most important long-term outcomes that should be evaluated.
Academic background in a health, education or social science-related discipline and relevant background experience. Expereince with Maori or Pacific health and culture an advantage. Examples include (but are not limited to) sociology, psychology, public health, obstetrics, midwifery, paediatrics, nursing.
i) To engage with a range of consumer groups to evaluate what outcomes they consider important and should be assessed at follow-up;
ii) Assess enablers and barriers to participation in follow-up;
iii) Using this information, in collaboration with consumers, promote enablers and address identified barriers to participation, and monitor their effect on participation rates in follow-up studies.
- What do families want to know about outcomes after trials of new treatments in pregnancy and the newborn?
- Childhood outcomes after dextrose gel for preventing low glucose levels in babies
- Childhood outcomes after a trial of extra protein for babies born very preterm
- Do lower thresholds for diagnosis of gestational diabetes have later benefits for mothers and babies?
- Does exposure to antenatal steroids alter cardiovascular risk in middle age?